Cargando…

Thymic tumours and their special features

Thymic tumours are rare thoracic malignancies, that may be aggressive and difficult to treat. The pillars of the management include pathological review, consideration of differential diagnoses, staging and multidisciplinary discussion. Assessment of resectability is key to drive the treatment sequen...

Descripción completa

Detalles Bibliográficos
Autores principales: Basse, Clémence, Girard, Nicolas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488894/
https://www.ncbi.nlm.nih.gov/pubmed/34670805
http://dx.doi.org/10.1183/16000617.0394-2020
_version_ 1784792762879574016
author Basse, Clémence
Girard, Nicolas
author_facet Basse, Clémence
Girard, Nicolas
author_sort Basse, Clémence
collection PubMed
description Thymic tumours are rare thoracic malignancies, that may be aggressive and difficult to treat. The pillars of the management include pathological review, consideration of differential diagnoses, staging and multidisciplinary discussion. Assessment of resectability is key to drive the treatment sequencing. Association with autoimmune diseases, especially myasthenia gravis, is observed, which impacts the oncological management. Networks are being built at the national and international levels. This article provides an overview of the most recent findings in the diagnosis, staging, histology, and management strategies of thymic tumours.
format Online
Article
Text
id pubmed-9488894
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher European Respiratory Society
record_format MEDLINE/PubMed
spelling pubmed-94888942022-11-14 Thymic tumours and their special features Basse, Clémence Girard, Nicolas Eur Respir Rev Series Thymic tumours are rare thoracic malignancies, that may be aggressive and difficult to treat. The pillars of the management include pathological review, consideration of differential diagnoses, staging and multidisciplinary discussion. Assessment of resectability is key to drive the treatment sequencing. Association with autoimmune diseases, especially myasthenia gravis, is observed, which impacts the oncological management. Networks are being built at the national and international levels. This article provides an overview of the most recent findings in the diagnosis, staging, histology, and management strategies of thymic tumours. European Respiratory Society 2021-10-20 /pmc/articles/PMC9488894/ /pubmed/34670805 http://dx.doi.org/10.1183/16000617.0394-2020 Text en Copyright ©The authors 2021 https://creativecommons.org/licenses/by-nc/4.0/This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org (mailto:permissions@ersnet.org)
spellingShingle Series
Basse, Clémence
Girard, Nicolas
Thymic tumours and their special features
title Thymic tumours and their special features
title_full Thymic tumours and their special features
title_fullStr Thymic tumours and their special features
title_full_unstemmed Thymic tumours and their special features
title_short Thymic tumours and their special features
title_sort thymic tumours and their special features
topic Series
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488894/
https://www.ncbi.nlm.nih.gov/pubmed/34670805
http://dx.doi.org/10.1183/16000617.0394-2020
work_keys_str_mv AT basseclemence thymictumoursandtheirspecialfeatures
AT girardnicolas thymictumoursandtheirspecialfeatures